Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 27, Issue 5, 2002, Pages 619-627

  Ramalho, Anabela S ^a   Beck, Sebastian ^a   Meyer, Michelle ^a   Penque, Deborah ^a   Cutting, Garry R ^a   Amaral, Margarida D ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036846329     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2001-0004OC     Document Type: Article

References (22)

1. Welsh, M. J., B. W. Ramsey, F. Accurso, and G. R. Cutting, 2001. Cystic fibrosis. In The Molecular and Metabolic Basis of Inherited Disease. C. L. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York. 5121-5188.
2. Chu, C. S., B. C. Trapnell, S. Curristin, G. R. Cutting, and R. G. Crystal. 1993. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat. Genet. 3:151-156.
3. Rave-Harel, N., E. Kerem, M. Nissim-Rafinia, 1. Madjar, R. Goshen, A. Augarten, A. Rahat, A. Hurwitz, A. Darvasi, and B. Kerem. 1997. The molecular basis of partial penetrance of splicing mutations in cystic fibrosis. Am. J. Hum. Genet. 60:87-94.
4. Amaral, M.D., P. Pacheco, S. Beck, C. Farinha, D. Penque, P. Nogueira, C. Barreto, B. Lopes, T. Casals, J. Dapena, S. Gartner, C. Vazquez, J. Perez-Frias, C. Olveira, R. Cabanas, X. Estivill, M. Tzetis, S. Doudounakis, T. Dork, E. Girodon-Boulandet, C. Cazeneuve, M. Goossens, M. Blayau. C. Verlingue, I. Vieira, C. Ferec. M. Claustres, M. des Georges, P. Birembaut, D. Hubert, T. Bienvenu, M. Adoun, J.-C. Chomel, K. De Boeck, H. Cuppens, and J. Lavinha. 2001. Cystic fibrosis patients with the 3272-26A>G splicing mutation have milder disease than F508del homozygotes: A large European study. J. Med. Genet. 38:777-782.
5. Beck, S., D. Penque, S. Garcia, A. Gomes, C. Farinha, L. Mata, S. Gulbenkian, K. Gil-Ferreira, A. Duarte, P. Pacheco, C. Barreto, B. Lopes, J. Cavaco, J. Lavinha, and M. D. Amaral. 1999. Cystic fibrosis patients with the 3272-26A>G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane. Hum. Mutat. 14:133-144.
6. Chu, C. S., B. C. Trapnell, J. J. Murtagh, Jr., J. Moss, W. Dalemans, S. Jallat, A. Mercenier, A. Pavirani, J. P. Lecocq, and G. R. Cutting. 1991. Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium. EMBO J. 10:1355-1363.
7. Frischmeyer, P. A., and H. C. Dietz. 1999. Nonsense-mediated mRNA decay in health and disease. Hum. Mol. Genet. 8:1893-1900.
8. Highsmith, W. E., L. H. Burch, Z. Zhou, J. C. Olsen, T. E. Boat, A. Spock, J. D. Gorvoy, L. Quittel, K. J. Friedman, and L. M. Silverman. 1994. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N. Engl. J. Med. 331:974-980.
9. Jarvi, K., J. Zielenski, M. Wilschanski, P. Durie, M. Buckspan, E. Tullis, D. Markiewicz, and L. C. Tsui. 1995. Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia. Lancet 345:1578. (letter)
10. Highsmith, W. E., Jr., L. H. Burch, Z. Zhou, J. C. Olsen, T. V. Strong, T. Smith, K. J. Friedman, L. M. Silverman, R. C. Boucher, F. S. Collins, and M. R. Knowles. 1997. Identification of a splice site mutation (2789 +5 G > A) associated with small amounts of normal CFTR mRNA and mild cystic fibrosis. Hum. Mutat. 9:332-338.
11. Yoshimura, K., H. Nakamura, B. C. Trapnell, W. Dalemans, A. Pavirani. J. P. Lecocq, and R. G. Crystal. 1991. The cystic fibrosis gene has a "housekeeping"-type promoter and is expressed at low levels in cells of epithelial origin. J. Biol. Chem. 266:9140-9144.
12. Wang, A. M., M. V. Doyle, and D. F. Mark. 1989. Quantitation of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86:9717-9721.
13. Pannetier, C., S. Delassus, S. Darche, C. Saucier, and P. Kourilsky. 1993. Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res. 21:577-583.
14. Abbott, M. A., B. J. Poiesz, B. C. Byrne, S. Kwok, J. J. Sninsky, and G. D. Ehrlich. 1988. Enzymatic gene amplification: Qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J. Infect. Dis. 158:1158-1169.
15. Singer-Sam, J., M. O. Robinson, A. R. Bellve, M. I. Simon, and A. D. Riggs. 1990. Measurement by quantitative PCR of changes in HPRT, PGK-1, PGK-2. APRT, MTase, and Zfy gene transcripts during mouse spermatogenesis. Nucleic Acids Res. 18:1255-1259.
16. Salomon, R. N., R. Underwood, M. V. Doyle, A. Wang, and P. Libby. 1992. Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. Proc. Natl. Acad. Sci. USA 89:2814-2818.
17. Mak, V., K. A. Jarvi, J. Zielenski, P. Durie, and L. C. Tsui. 1997. Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens. Hum. Mol. Genet. 6:2099-2107.
18. Trapnell, B. C., P. L. Zeitlin, C. S. Chu, K. Yoshimura, H. Nakamura, W. B. Guggino, J. Bargon, T. C. Banks, W. Dalemans, and A. Pavirani. 1991. Down-regulation of cystic fibrosis gene mRNA transcript levels and induction of the cystic fibrosis chloride secretory phenotype in epithelial ceils by phorbol ester. J. Biol. Chem. 266:10319-10323.
19. Dörk, T., K. Will, K. Grade, M. Krawczak, and B. Tümmler. 1994. A 32-bp deletion (2991del32) in the cystic fibrosis gene associated with CFTR mRNA reduction. Hum. Mutat. 4:65-70.
20. Duarte, A., M. Amaral, C. Barreto, P. Pacheco, and J. Lavinha, 1996. Complex cystic fibrosis allele R334W-R1158X results in reduced levels of correctly processed mRNA in a pancreatic sufficient patient. Hum. Mutat. 8:134-139.
21. French, P. J., J. H. van Doorninck, R. H. Peters, E. Verbeek, N. A. Ameen, C. R. Marino, H. R. de Jonge, J. Bijman, and B. J. Scholte. 1996. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo. J. Clin. Invest. 98:1304-1312.
22. Will, K., T. Dörk, M. Stuhrmann, H. von der Hardt, H. Ellemunter, B. Tümmler, and J. Schmidtke. 1995. Transcript analysis of CFTR nonsense mutations in lymphocytes and nasal epithelial cells from cystic fibrosis patients. Hum. Mutat. 5:210-220.